Minoxidil
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse.
The active substance of Agrocia is minoxidil. Agrocia is used to treat male pattern baldness (androgenetic alopecia).
Male pattern baldness can be recognized by a bald spot on the top of the head (in the tonsure area).
Agrocia, 50 mg/mL, should not be used in women.
Before starting treatment with Agrocia, the patient should discuss it with their doctor or pharmacist.
and (or) structure of the hair.
Do not inhale the aerosol.
There have been cases of excessive hair growth on the body of infants following contact with the skin of areas where minoxidil has been applied to patients (caregivers) using topical minoxidil.
Hair growth returned to normal within a few months when the infant was no longer exposed to minoxidil.
Caution should be exercised to avoid contact between children and areas of the body where minoxidil has been applied topically.
If excessive hair growth on the body of a child is observed during the use of products containing minoxidil, a doctor should be consulted.
The use of Agrocia should be discontinued and a doctor consulted if hypotension or chest pain, rapid heart rate, fainting, or dizziness, sudden, unexplained weight gain, swelling of the hands or feet, or persistent redness or irritation of the scalp occurs.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
The use of Agrocia with vasodilators (medicines used to treat cerebrovascular disorders) and medicines used to treat high blood pressure (such as guanethidine and its derivatives) may cause a sudden decrease in blood pressure.
This medicine should not be applied simultaneously with other topical medicines and hair products, such as corticosteroids, retinoids, such as tretinoin creams or ointments with occlusive effects, as they may increase the absorption of the medicine.
Betamethasone dipropionate (a medicine used to treat skin diseases) may decrease the systemic absorption of Agrocia.
When used concomitantly with cyclosporine administered systemically (a medicine that prevents organ transplant rejection), excessive hair growth may occur.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Agrocia is not recommended during pregnancy and breastfeeding.
Although there is no data to suggest that Agrocia affects the ability to drive or use machines, these activities should be avoided until it is established how the patient tolerates the medicine.
Agrocia contains 243 mg of alcohol (96% ethanol) in each mL of the solution for the skin. The medicine may cause a burning sensation on damaged skin. Due to the ethanol content, the medicine is flammable. It should not be used near an open flame, a lit cigarette, or certain devices (such as hair dryers).
Agrocia contains 520 mg of propylene glycol in each mL of the solution for the skin.
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse. If in doubt, the patient should consult their doctor, pharmacist, or nurse.
The recommended daily dose is 1 mL of the solution (10 sprays of the aerosol using the dosing pump) twice a day.
Agrocia stabilizes the process of male pattern baldness (androgenetic alopecia) in the tonsure area of the scalp in men. Treatment may therefore stop the progression of androgenetic alopecia. The onset and degree of response to treatment vary from patient to patient; however, individual reactions cannot be predicted due to the lack of available data.
Treatment should not be discontinued too early, as discontinuation of treatment may cause a return to the initial state of baldness before starting treatment within 3 to 4 months.
As with other medicines, the degree of response to treatment varies from patient to patient, so it may be necessary to use the medicine for a period of 4 months to achieve noticeable hair growth. During long-term use, the effects of treatment remain unchanged over time. If no improvement in hair growth is observed after 6 months, treatment should be discontinued.
Dosing
For topical use only. DO NOT SWALLOW THE MEDICINE.
The recommended daily dose is 1 mL of the solution (10 sprays of the aerosol using the dosing pump) twice a day.
The maximum daily dose is 2 mL.
The recommended daily dose should be followed, regardless of the size of the bald area of the scalp.
If the patient feels that the effect of Agrocia is too strong or too weak, they should consult their doctor or pharmacist.
Agrocia should not be used in patients under 18 years of age, as its efficacy and safety in this age group have not been established.
Agrocia should not be used in patients over 65 years of age, as its efficacy and safety in this age group have not been established.
If a dose of Agrocia greater than the recommended dose is used, the patient should immediately consult their doctor or pharmacist.
Accidental or intentional overdose of Agrocia may cause an increase in skin-related side effects, such as itching (pruritus), dryness, irritation, and rash (acute or chronic inflammatory skin diseases).
Subjective and objective symptoms after accidental or intentional ingestion of Agrocia may include hypotension (decreased blood pressure), tachycardia (rapid heart rate), edema (swelling), and congestive heart failure (heart failure).
In case of overdose or accidental ingestion, medical help should be sought immediately, and the amount of medicine taken should be reported.
The next dose should be applied, and then the normal treatment schedule should be resumed. A double dose should not be applied to make up for a missed dose.
If treatment with Agrocia is discontinued, the baldness may recur, and the patient's condition may return to what it was before treatment within 3 to 4 months.
If such symptoms occur, the patient should discuss them with their doctor.
If the patient has any further doubts about the use of this medicine, they should consult their doctor or pharmacist.
The patient should immediately consult their doctor if they experience any of the following symptoms, as urgent treatment may be necessary.
Swelling of the face, lips, or throat, which makes swallowing or breathing difficult. These may be symptoms of a severe allergic reaction (frequency not known, cannot be estimated from the available data).
Like all medicines, Agrocia can cause side effects, although not everybody gets them.
The most common side effects are: itching (pruritus), skin inflammation (redness), dryness, irritation, rash (inflammatory skin disease), and excessive hair growth (excessive hair growth on the skin). These effects are usually mild to moderate and reversible after discontinuation of treatment.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 10,000 people):
Not known(frequency cannot be estimated from the available data)
If the patient experiences any side effects, including those not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storage of the medicinal product.
Do not use this medicine after the expiry date stated on the bottle and carton after "EXP" and "Expiry date (EXP)". The expiry date refers to the last day of the month.
Shelf life after first opening the bottle: 30 days.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Agrocia is minoxidil: each mL of the solution contains 50 mg of minoxidil.
One mL of the solution corresponds to 10 sprays.
The other ingredients (excipients) are: 96% ethanol, propylene glycol, and purified water.
Agrocia is a solution for the skin. The solution is clear, colorless, or slightly yellowish, with an alcoholic odor.
Agrocia is available in an HDPE bottle with a PP cap and a PP dosing pump, in a cardboard box. The pack contains 60 mL of the solution or 120 mL of the solution (2 x 60 mL).
Medical Valley Invest AB
Brädgårdsvägen 28
236 32 Höllviken
Sweden
Industrial Farmacéutica Cantabria S.A.
Barrio Solía, nº 30
La Concha, Villaescusa
39690 Santander, Cantabria
Spain
Date of last revision of the leaflet:08/2024
Detailed information about this medicine can be found on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products http://urpl.gov.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.